Key Market Indicators
Sales of hypnotic and sedative medicines in Finland are expected to reach nearly $17 million by 2026. In 2021, Finnish sales of these medicines stood at $16.2 million, a 0.9% increase from the year before. This growth rate has been consistent since 2003. Denmark topped the ranking of hypnotic and sedative medicine sales in 2021, with $16.2 million. Germany, Sweden and Belgium followed, respectively, with $15.2 million, $14.3 million and $13.2 million.
